TIAA CREF Investment Management’s Anavex Life Sciences AVXL Stock Holding History

TIAA CREF Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-105,904	Closed	-$292K	–	3081
2018 Q1	$292K	Buy	105,904 +15,751	+17%	+$44.5K	﹤0.01%	2907
2017 Q4	$290K	Sell	90,153 -6,823	-7%	-$26.9K	﹤0.01%	2948
2017 Q3	$401K	Hold	96,976	–	–	﹤0.01%	2923
2017 Q2	$516K	Sell	96,976 -29,562	-23%	-$171K	﹤0.01%	2855
2017 Q1	$726K	Sell	126,538 -42,897	-25%	-$222K	﹤0.01%	2658
2016 Q4	$671K	Buy	169,435 +51,264	+43%	+$183K	﹤0.01%	2722
2016 Q3	$429K	Buy	118,171 +25,129	+27%	+$106K	﹤0.01%	2914
2016 Q2	$568K	Buy	+93,042	New	+$449K	﹤0.01%	2808

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ECM

Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TIAA CREF Investment Management's AVXL Position: Q2 2018 in Review

TIAA CREF Investment Management sold out of Anavex Life Sciences (AVXL) in Q2 2018, closing a stake of 105,904 shares — an estimated $292K sold.

TIAA CREF Investment Management first reported a position in AVXL in Q2 2016 and held it in 8 quarters. The position peaked at $726K in Q1 2017. 57 funds tracked by Wall St. Rank hold AVXL as of Q2 2018.

TIAA CREF Investment Management reported no remaining Anavex Life Sciences position as of Q2 2018 after selling out during the quarter.
TIAA CREF Investment Management sold 105,904 Anavex Life Sciences shares in Q2 2018, an estimated $292K.
TIAA CREF Investment Management first reported a position in Anavex Life Sciences in Q2 2016 and held it in 8 quarters.
TIAA CREF Investment Management's Anavex Life Sciences position peaked at $726K in Q1 2017.
57 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2018.

Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.